Neuro-ophthalmic complications in giant cell arteritis

Related Experiment Video

Updated: Jul 3, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Frances A Borg1, Victoria L J Salter, Bhaskar Dasgupta

  • 1Department of Rheumatology, Southend University Hospital, Prittlewell Chase, Westcliffe-on-Sea, Essex, SS0 0RY, UK.

Current Allergy and Asthma Reports
|July 9, 2008
PubMed

Insights

Giant cell arteritis (GCA) is a medical emergency. Prompt recognition and treatment are crucial to prevent permanent vision loss, often linked to jaw claudication and temporal artery issues.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a critical medical emergency causing systemic inflammation and ischemia.
  • Neuro-ophthalmic complications, including permanent vision loss, occur early in up to 20% of patients.
  • Delayed recognition and treatment are primary drivers of vision loss in GCA.

Purpose of the Study:

  • To highlight the importance of early GCA recognition and treatment.
  • To identify symptoms and signs predictive of permanent visual loss.
  • To review diagnostic modalities and therapeutic strategies for GCA.

Main Methods:

  • Review of clinical presentation, diagnostic features, and imaging techniques for GCA.
  • Analysis of histopathologic findings, specifically intimal hyperplasia.
  • Evaluation of current and potential therapeutic interventions, including corticosteroids and biologics.

Main Results:

  • Jaw claudication and temporal artery abnormalities are predictive of permanent visual loss.
  • Some GCA patients exhibit muted inflammatory responses.
  • Intimal hyperplasia on temporal artery biopsy correlates with neuro-ophthalmic complications.

Conclusions:

  • Early identification of GCA symptoms like jaw claudication is vital for preventing vision loss.
  • While imaging shows promise, temporal artery biopsy remains the gold standard.
  • Corticosteroids are the primary treatment; disease-modifying and biologic therapies require further study for steroid-sparing effects.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...